本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

天美生物

0.0574
+0.00264.74%
盘后0.05800.0006+1.05%19:56 EDT
成交量:904.56万
成交额:51.87万
市值:71.77万
市盈率:0.34
高:0.0599
开:0.0515
低:0.0515
收:0.0548
数据加载中...
2025/04/16

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2025/04/02

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/14

SEC问询函

Form CORRESP - Correspondence
2025/03/14

SEC问询函

Form CORRESP - Correspondence
2025/03/13

SEC问询函

Form CORRESP - Correspondence
2025/03/13

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/03/06

SEC问询函

Form CORRESP - Correspondence
2025/03/03

SEC问询函

Form CORRESP - Correspondence
2025/03/03

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/02/19

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/02/18

SEC问询函

Form CORRESP - Correspondence
2025/01/28

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/17

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/01/16

SEC问询函

Form CORRESP - Correspondence
2024/11/19

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/10/11

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/10/11

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/02/09

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/05/15

SEC问询函

Form CORRESP - Correspondence
2023/05/15

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]